Study validates shorter treatment for major world infection, tuberculosis: Four-month TB therapy…
Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time by a third. Coauthors including…